|
|
|
|
| Join leading experts for an insightful discussion on the evolution of targeted protein degradation (TPD) and its growing impact on drug discovery. Explore advances in PROTACs, molecular glues, discovery technologies, modality selection, translational challenges, and safety considerations. Learn how TPD is unlocking new therapeutic opportunities for previously undruggable targets and shaping the future of drug development. Register for free on Drug Discovery Online. |
|
|
|
|
By Ray Dogum, chief editor, Drug Discovery Online | Nucleate Boston’s 2026 Activator shows how mentorship, structure, and community can help promising young scientists become credible biotech founders. | |
|
|
|
|
If AI Can't Read Your Science, Investors Won't Either | By Holley Miller, Grey Matter Marketing | As investors deploy AI to screen thousands of deals at once, life sciences founders who keep their story locked behind NDAs risk never making it past the first automated filter. |
|
|
|
|
|
| Modeling Colorectal Cancer Progression | Webinar | Emulate | Gain a better understanding of the microenvironment's role in colorectal cancer progression by reviewing the integration of Organ-Chip models with mass spectrometry-based metabolomics. |
|
|
| Particle Engineering For Inhalation Drug Delivery | Application Note | By Matthew Ferguson, Lonza | Explore key parameters for choosing the right particle engineering approach to meet dry powder inhaler (DPI) target product profiles for inhalation-based drug products. |
|
|
|
|
|
|
